MedTrace Logo

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

NCT01052363 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-02-09

No results posted yet for this study

Summary

Pilot Trial of CA4P with Avastin in Recurrent Gliomas

Conditions

Interventions

DRUG

Bevacizumab, CA4P

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Principal Investigators

  • Ramin Altaha, MD · West Virginia University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052363 on ClinicalTrials.gov